IRIS
MAPELLI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.069
NA - Nord America 2.750
AS - Asia 2.523
SA - Sud America 516
Continente sconosciuto - Info sul continente non disponibili 231
AF - Africa 49
OC - Oceania 20
Totale 9.158
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.613
RU - Federazione Russa 1.583
SG - Singapore 823
CN - Cina 774
IT - Italia 497
BR - Brasile 406
HK - Hong Kong 274
SE - Svezia 265
VN - Vietnam 242
BD - Bangladesh 164
DE - Germania 156
FR - Francia 125
ES - Italia 106
FI - Finlandia 98
GB - Regno Unito 88
IN - India 74
CA - Canada 68
AR - Argentina 41
MX - Messico 35
PL - Polonia 35
NL - Olanda 25
ID - Indonesia 24
IE - Irlanda 23
TR - Turchia 23
JP - Giappone 22
ZA - Sudafrica 20
AT - Austria 19
AU - Australia 19
EC - Ecuador 18
IQ - Iraq 15
CO - Colombia 14
CL - Cile 12
MY - Malesia 10
PK - Pakistan 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
PY - Paraguay 9
JM - Giamaica 8
LT - Lituania 8
MA - Marocco 8
MD - Moldavia 8
PE - Perù 7
PT - Portogallo 7
UA - Ucraina 7
JO - Giordania 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
IL - Israele 5
NP - Nepal 5
PH - Filippine 5
BE - Belgio 4
IR - Iran 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HN - Honduras 3
KR - Corea 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
AW - Aruba 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KZ - Kazakistan 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
MR - Mauritania 1
NI - Nicaragua 1
PR - Porto Rico 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 8.931
Salva come PNG Salva come JPEG
Città #
Dallas 585
Singapore 413
Ashburn 340
Moscow 324
Hong Kong 271
San Jose 251
Milan 193
Shanghai 147
New York 142
Beijing 141
Council Bluffs 109
Hefei 92
Ho Chi Minh City 87
Valencia 86
Lauterbourg 79
Munich 75
Santa Clara 71
Lawrence 63
Los Angeles 63
Princeton 63
Hanoi 56
Turku 50
Boardman 47
Orem 42
Helsinki 41
Rome 39
São Paulo 37
Montreal 26
Brooklyn 24
Chennai 24
Warsaw 24
Chicago 23
Dublin 23
London 21
Frankfurt am Main 20
Atlanta 17
Manchester 17
Naples 17
Toronto 17
Mumbai 16
Poplar 15
Seattle 15
Stockholm 15
Tokyo 15
The Dalles 14
Ankara 13
Buffalo 13
Columbus 13
Denver 13
Phoenix 13
Amsterdam 12
Boston 12
Da Nang 12
Guangzhou 12
Houston 12
Johannesburg 12
Haiphong 11
Mexico City 11
Nuremberg 11
Philadelphia 11
Washington 11
New Delhi 10
Rio de Janeiro 10
San Francisco 10
Bexley 9
Falkenstein 9
Tashkent 9
Belo Horizonte 8
Dhaka 8
Fortaleza 8
Secaucus 8
West Jordan 8
Hangzhou 7
Lappeenranta 7
Quito 7
Santiago 7
Turin 7
Vienna 7
Barnet 6
Canberra 6
Curitiba 6
Figino 6
Guayaquil 6
Kingston 6
Kuala Lumpur 6
Lima 6
Miami 6
Shenzhen 6
Adelaide 5
Amman 5
Baghdad 5
Bologna 5
Brasília 5
Brescia 5
Can Tho 5
Changsha 5
Cleveland 5
Florence 5
Genoa 5
Guarulhos 5
Totale 4.701
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 280
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 199
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 189
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 188
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 187
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 182
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 174
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 168
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 163
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 161
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 152
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 151
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 138
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 136
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 133
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 133
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 133
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 132
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 130
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 129
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 127
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 125
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 122
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 122
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 122
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 122
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 121
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 119
Hypoxia pathway: 18F-FAZA 118
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 118
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 115
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 115
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 114
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 112
Clinical implication of multimodality imaging of aortic root intramural hematoma 111
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 110
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 109
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 106
[Multi-modality imaging: mycotic abscess of a pericardial patch]. FT Imaging multimodale: ascesso micotico su patch di pericardio 106
Association of IgG4-related disease and systemic rheumatic disorders 105
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 104
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 102
Radiomics and artificial intelligence 99
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 99
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 97
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 90
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 89
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 85
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 83
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 82
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 82
Imaging in evaluation of response to neo-adjuvant treatment 76
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 75
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 74
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 74
PET/MRI and prostate cancer 71
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 71
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 70
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 70
Nuclear medicine in prostate cancer management 68
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 65
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 64
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 62
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 60
PET/MRI 58
Hypoxia18F-FAZA PET/CT imaging in lung cancer and high-grade glioma: open issues in clinical application 58
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer 57
PET imaging for lymph node dissection in prostate cancer 56
Evaluation of prostate cancer with11C-Choline PET/CT for treatment planning, response assessment, and prognosis 56
Initial prostate cancer diagnosis and disease staging - The role of choline-PET-CT 55
PET/MRI in Neuroendocrine Tumours: Blessings and Curses 55
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 55
Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia 53
Incidental Finding of Parathyroid Adenoma With C-11-Choline PET/CT 53
Lymph nodal metastases: diagnosis and treatment 52
Sarcoidosis mimicking metastatic gynaecological malignancies: A diagnostic and therapeutic challenge? 51
FDG-PET/CT predicts outcome in oropharingeal carcinoma patients undergoing intensity modulated radiation therapy with dose escalation to FDG-avid tumour volumes 51
Clinical PET imaging of tumour hypoxia in lung cancer 51
POSITRON EMISSION TOMOGRAPHY/MAGNETIC RESONANCE IMAGING 50
The relationship between gleason score and 11c-choline pet/ct positive detection rate in prostate cancer patients with biochemical failure after radical prostatectomy: biological and methodological factors 49
PET/MRI in gynecological tumors 49
PET guidance in prostate cancer radiotherapy: Quantitative imaging to predict response and guide treatment 49
Imaging biomarkers in prostate cancer: role of PET/CT and MRI 49
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 49
Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT 48
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL 48
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery 47
Detection of bone metastases and evaluation of therapy response in prostate cancer patients by radiolabelled choline PET/CT 46
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 46
Prostate cancer recurrence: can PSA guide imaging? 46
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by F-18-FDG PET/CT 45
Reply to the letter "Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients" 44
Erdheim-Chester Disease Imaging-Guided Therapeutic Approach 42
High-grade endometrial cancer: value of [F-18]FDG PET/CT in preoperative staging 41
TECNICHE, METODOLOGIE, APPLICAZIONI DIAGNOSTICA PER IMMAGINI 41
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on F-18-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 40
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 36
Per-Lesion Assessment of Individual MRI Sequences and 68Ga-DOTATATE PET in Neuroendocrine Liver Metastases 20
Hybrid [18F]FDG PET/MR Imaging Parameters for the Prediction of Tissue Biomarkers in Invasive Ductal Breast Cancer 10
B-cell depletion with obinutuzumab for the treatment of IgG4-related disease 6
Totale 9.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022106 0 6 0 31 11 5 9 11 14 11 2 6
2022/2023526 145 95 42 30 20 49 39 52 9 22 3 20
2023/2024604 44 27 109 64 40 91 22 56 9 20 33 89
2024/20251.475 144 33 43 41 88 113 264 140 173 145 122 169
2025/20265.879 392 378 725 710 447 172 447 398 1.452 338 160 260
2026/2027498 285 213 0 0 0 0 0 0 0 0 0 0
Totale 9.158